Nanion Upcoming Events

You are viewing the list of upcoming events.
Switch to past events instead.


On-Demand | NANION & Friends - Virtual Meeting

201026 2020 vum now available on demand

Meeting Venue: Virtual Meeting Week (All Content Accessible Live and On-Demand)

Welcome to the 2020 Nanion User Meeting!

Our highly anticipated event has drawn over a hundred registrants so far; ranging from academia to industry. 
The User Meeting will also include select posters and application notes.

Date and time:
Start: Monday October 12th
End: Friday October 16th


Read the preliminary agenda of the User Meeting here:

Agenda 


Confirmed Speakers:

Prof. Dr. med. Angelika Lampert 
Uniklinik RWTH Aachen
Title: "The Sodium Channel Network Aachen meets the SyncroPatch"

Dr. Fernanda Laezza
Department of Pharmacology & Toxicology - University of Texas Medical Branch
Title: "From manual to automated planar patch-clamp electrophysiology: accelerating drug discovery research in academic settings"

Dr. Lei Wang
The Broad Institue of MIT and Harvard 
Title: "PatchAnalytics - Jen Q Pan’s Lab"

Dr. Judith Stolwijk
University Hospital Regensburg & University of Regensburg
Title: Impedance measurements and Calcium imaging to investigate the role of store operated Ca2+ entry in GPCR-mediated endothelial barrier regulation

Michael Skiba
University of Regensburg
Title: "Profiling the pharmacology of G-Protein coupled receptors (GPCR) in cell-based assays using label-free impedance analysis"

Dr. Matthias Quick
Columbia University
Title: "Employing SSM electrophysiology to capture electrogenic fluxes in membrane proteins"

Prof. Dr. Stefan Mergler
Charité - Universitätsmedizin Berlin
Title: "TRP channels in human corneal cells and their role in ophthalmology"

Dr. András Horváth
Application Scientist - Nanion Technologies
Title: "Measurement of Transient receptor potential cation (TRP) channels using the Patchliner and Port-a-Patch"

Dr. Marc Rogers 
Chief Scientific Officer | Metrion Biosciences

Title: "Development and validation of ASIC1a ligand-gated ion channel drug discovery assays on automated patch clamp platforms"

Dr. Omar Alijevic 
Philip Morris International
Title: "Pharmacological Characterization of Natural Tobacco Alkaloids in the Presence of Positive Allosteric Modulators Against Humana4b2 and a7 Nicotinic Acetylcholine Receptors"

Dr. Carmine Gentile
University of Technology Sydney
Title: "Pharmacological Characterization of Natural Tobacco Alkaloids in the Presence of Positive Allosteric Modulators Against Humana4b2 and a7 Nicotinic Acetylcholine Receptors"

Dr. Alison Obergrussberger 
Scientific Communications Manager - Nanion Technologies
Title: "Benchmarking best practices and calibration standards for HTS hERG recordings for improved proarrhythmic assessment"

Dr. Sonja Stölzle-Feix
Director Scientific Affairs & Product Manager of CardioExcyte/FLEXcyte - Nanion Technologies 
Title: "ICH S7B best practices considerations - New Q&As"

Dr. Matthias Gossmann 
co-founder and CEO (innoVitro GmbH)
Title: "Taking the FLEXcyte 96 to a new dimension: Integration of mechanical stimulation into a high-throughput cardiac contractility assay"

Dr. Tamer M. Mohamed
University of Louisville

Title: "Heart slice culture system reliably demonstrates clinical drug-related cardiotoxicity"

Dr. Orvos Péter

University of Szeged
Title: "Evaluation of possible proarrhythmic potency: variability of IC50 values of drugs under different  conditions and in different platforms"

Prof. Tamer M. Gamal El-Din 
University of Washington (Seattle) 
Title: "Voltage-Gated Ion Channels Fenestrations as a Drug Access Pathway"


Receive Updates:

Please subscribe to our Newsletter and we will keep you informed.

Back to Overview

 

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.